Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours

Immune checkpoint inhibitors (ICIs) have been developed for canine tumour treatment, and pilot clinical studies have demonstrated their antitumour efficacy in dogs with oral malignant melanoma (OMM). Although ICIs have been approved for various human malignancies, their clinical benefits in other tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Maekawa, Naoya, Konnai, Satoru, Hosoya, Kenji, Kim, Sangho, Kinoshita, Ryohei, Deguchi, Tatsuya, Owaki, Ryo, Tachibana, Yurika, Yokokawa, Madoka, Takeuchi, Hiroto, Kagawa, Yumiko, Takagi, Satoshi, Ohta, Hiroshi, Kato, Yukinari, Yamamoto, Satoshi, Yamamoto, Keiichi, Suzuki, Yasuhiko, Okagawa, Tomohiro, Murata, Shiro, Ohashi, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550157/
https://www.ncbi.nlm.nih.gov/pubmed/37792729
http://dx.doi.org/10.1371/journal.pone.0291727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550157/
https://www.ncbi.nlm.nih.gov/pubmed/37792729
http://dx.doi.org/10.1371/journal.pone.0291727

Ejemplares similares